Global Markets for Drug-Device Combinations

Global Markets for Drug-Device Combinations

Report Scope:

The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations’ current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.

Report Includes:

40 data tables and 43 additional tables

Overview of the global markets for drug-device combination (DDC) products and biological devices

Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029

Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application (disease area), and region

Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, prospects, product recalls, pipeline products, and the expected impact of macroeconomic factors

Review of the industry supply chain, using the Porter’s Five Forces model, to analyze the microand macro environmental factors prevailing in the marketplace

Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices

An analysis of the industry structure, including companies’ market shares, alliances, M&A activity and venture funding outlook

Profiles of the leading market players, including Medtronic, Boston Scientific Corp., Stryker, Abbott, and BD

Companies Mentioned

3M
ABBOTT
B. BRAUN SE
BD
BOSTON SCIENTIFIC CORP.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
SMITH+NEPHEW
STRYKER
TERUMO CORP.